GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » Price-to-Free-Cash-Flow

Instituto Rosenbusch (BUE:ROSE) Price-to-Free-Cash-Flow : 7.68 (As of May. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Instituto Rosenbusch Price-to-Free-Cash-Flow?

As of today (2024-05-29), Instituto Rosenbusch's share price is ARS114.25. Instituto Rosenbusch's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ARS14.87. Hence, Instituto Rosenbusch's Price-to-Free-Cash-Flow Ratio for today is 7.68.

The historical rank and industry rank for Instituto Rosenbusch's Price-to-Free-Cash-Flow or its related term are showing as below:

BUE:ROSE' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.73   Med: 15.17   Max: 3400
Current: 7.68

During the past 13 years, Instituto Rosenbusch's highest Price-to-Free-Cash-Flow Ratio was 3400.00. The lowest was 2.73. And the median was 15.17.

BUE:ROSE's Price-to-Free-Cash-Flow is ranked worse than
76.06% of 518 companies
in the Drug Manufacturers industry
Industry Median: 23.37 vs BUE:ROSE: 7.68

Instituto Rosenbusch's Free Cash Flow per Share for the three months ended in Mar. 2024 was ARS12.80. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ARS14.87.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 16.50% per year.

During the past 13 years, Instituto Rosenbusch's highest 3-Year average Free Cash Flow per Share Growth Rate was 477.40% per year. The lowest was -72.90% per year. And the median was 4.80% per year.


Instituto Rosenbusch Price-to-Free-Cash-Flow Historical Data

The historical data trend for Instituto Rosenbusch's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instituto Rosenbusch Price-to-Free-Cash-Flow Chart

Instituto Rosenbusch Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.55 7.80 8.64 7.77 27.49

Instituto Rosenbusch Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 23.59 27.49 7.83

Competitive Comparison of Instituto Rosenbusch's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instituto Rosenbusch's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Instituto Rosenbusch's Price-to-Free-Cash-Flow falls into.



Instituto Rosenbusch Price-to-Free-Cash-Flow Calculation

Instituto Rosenbusch's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=114.25/14.874
=7.68

Instituto Rosenbusch's Share Price of today is ARS114.25.
Instituto Rosenbusch's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS14.87.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Instituto Rosenbusch  (BUE:ROSE) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Instituto Rosenbusch Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Instituto Rosenbusch's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Instituto Rosenbusch (BUE:ROSE) Business Description

Traded in Other Exchanges
N/A
Address
Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.